AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Collaborative Development of Esketamine for Depression Treatment
This chapter explores the development of an intranasal esketamine formulation for depression, highlighting collaboration with the FDA on safety protocols and patient access. It also emphasizes the formulation's impact on reducing suicidal ideation, addressing a vital public health concern.